Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry

Autor:	Martinez-Cordero, Humberto, Abello-Polo, Virginia, Casas, Claudia, Solano, Maria-Helena, Espinosa, Daniel, Perdomo, Ivan, Reyez, Jheremy, Osuna, Monica, Paredes, Viviana, Figueroa, Jair, Gomez, Rigoberto, Jaramillo, Roberto, Gomez, Alvaro, Saavedra, Jose-Domingo, Galvez, Kenny, Quintero, Guillermo, Abenoza, Lina, Gaviria, Lina, Borjas, Yazmin, IdroboAsociacion Colombiana de Hematologia y OncologiaACHO-RENEHOC, Colombia;Universidad del Valle-Centro Julian Coronel,Santiago de Cali, Colombia, Henry
Zdroj:	Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS256-S256, 1p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect